Related to Tekmira Wins $34.7M Award to Develop RNAi Therapeutic against Ebola Virus

• MDRNA Revises Agreement with RiboTask for UNA Technology
  
• UK HIV Vaccine Consortium Orders Candidate Genes from Geneart
  
• CIRM Bankrolls 15 Stem Cell Research Grants with $40M
  
• NIH Doles Out $42M to Bolster the Human Microbiome Project
  
• Israeli Government Boosts Compugen Drug Discovery Funding with $400K
  
• Fast-Track and Atox Score $575K Grant to Move Septic Shock Treatment into Clinic
  
• NIH Sets Guidelines for Funding Research on Human Stem Cells
  
• Alnylam and Novartis Take RNAi Therapeutics Collaboration into Fifth Year
  
• NIH Bankrolls $10M for Albert Einstein College of Medicine to Study Motion-Induced Enzyme Changes
  
• Human Genome Sciences Receives $151M Order for Anthrax Drug from U.S. Government
  
• RXi Gains Rights to Advirna’s RNAi Delivery Platform
  
• University of Rhode Island Wins $13M Grant to Develop Vaccines for Emerging Infectious Diseases
  
• Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders
  
• Crucell and PATH Malaria Vaccine Program Get Funding to Develop a Prime-Boost Adenoviral Vaccine
  
• Apogenix Obtains Roughly $3.66M to Further Cancer and Inflammatory Disease Initiatives
  
• Neurotez Scores $2.73M to Progress Preclinical Leptin Therapy for Alzheimer’s Disease
  
• Grant to Pluristem Increased by $0.4M to Advance Cell Therapy for Critical Limb Ischemia
  
• Ichor and Partners Awarded $3.3M Grant to Develop Alzheimer’s Vaccine
  
• Crucell Wins $40.7M NIAID Contract to Develop Human Flu mAbs
  
• $1.3 Flemish Government Grant to Support Clinical Trials of ActoGeniX’ Oral Mucositis Therapy